TheEdgeResearch
Home / Stocks / LIFD

LFTD Partners Inc. (LIFD)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.20 ▲ +0.00%
Market Cap
$3.0M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.55
52-Wk Range
0.1-0.3
CEO
Gerard Jacobs
Country
US
Currency
USD

LFTD Partners Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Jacksonville, FL, US. The stock last traded at $0.20, up 0.00% on the session, giving a market capitalisation of $3.0M. On trailing twelve-month figures it carries a trailing P/E of -0.10, a net margin of -77.7%. Its beta of 1.55 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.10
Price / Sales
0.08
Price / Book
0.35
EV / EBITDA
-0.10
Gross margin
22.7%
Operating margin
-8.5%
Net margin
-77.7%
Return on equity
Debt / equity
0.21
Current ratio
2.26
Dividend yield
0.0%
Payout ratio
-0.0%
Company profile
Exchange
Other OTC
Employees
100
IPO date
2012-09-27
Headquarters
Jacksonville, FL, US
About LFTD Partners Inc.

LFTD Partners Inc., operating through its subsidiary Lifted Made, specializes in the production and distribution of two distinct product lines. The first consists of psychedelic products, marketed under their Silly Shruum brand. The second encompasses hemp-derived cannabinoid products, which they sell under the Urb Finest Flowers label. Established in 1986, the company was previously known as Acquired Sales Corp. before officially rebranding to LFTD Partners Inc. in September 2021. Its corporate headquarters are located in Jacksonville, Florida.

Comparable companies

LFTD Partners Inc. is most often compared with the following Healthcare names:

CANNCNGGFCPIVFCTABFMVMDFRPNRFRSCFRVVTFTGIFFTNRG
More research on LIFD
LIFD technical analysis LIFD TheEdge Score Compare against peers
Open full interactive analysis & DCF →